Edge River (DVA) is a medicare approved dialysis facility center in Yuma, Arizona and it has 13 dialysis stations. It is located in Yuma county at 1197 S Redondo Center Dr, Yuma, AZ, 85365. You can reach out to the office of Edge River (DVA) at (928) 329-4340. This dialysis clinic is managed and/or owned by Davita. Edge River (DVA) has the following ownership type - Profit. It was first certified by medicare in October, 2015. The medicare id for this facility is 032644 and it accepts patients under medicare ESRD program.
| Name | Edge River (DVA) |
|---|---|
| Location | 1197 S Redondo Center Dr, Yuma, Arizona |
| No. of Dialysis Stations | 13 |
| Medicare ID | 032644 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1197 S Redondo Center Dr, Yuma, Arizona, 85365 | |
| (928) 329-4340 | |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
| NPI Number | 1356745236 |
| Organization Name | Edge River Dialysis |
| Doing Business As | Shelling Dialysis Llc |
| Address | 1197 S Redondo Center Dr Yuma, Arizona, 85365 |
| Phone Number | (928) 329-4340 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 37 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 16 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 81 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 738 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 20 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 145 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 90 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Edge River (DVA) with elevated calcium levels.
| Patients with hypercalcemia | 102 |
| Hypercalcemia patient months | 885 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 109 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 54 |
| Patient months included in arterial venous fistula and catheter summaries | 427 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 76 |
| Hospitalization Rate in facility | 151.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 265.9 |
| Hospitalization Rate: Lower Confidence Limit | 89.7 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Edge River (DVA) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 33.5 |
| Readmission Rate: Lower Confidence Limit | 14.5 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Edge River (DVA) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .16 (Better than Expected) |
| SIR: Upper Confidence Limit | .79 |
| SIR: Lower Confidence Limit | .01 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Edge River (DVA)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 70 |
| Transfusion Rate in facility | 36.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 97.6 |
| Transfusion Rate: Lower Confidence Limit | 15.5 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Edge River (DVA) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 114 |
| Mortality Rate in facility | 12.5 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.7 |
| Mortality Rate: Lower Confidence Limit | 5 |
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago
News Archive
CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d'Acceleration du Transfert de Technologies Sud Est), to exploit two patents.
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition of the Journal of Clinical Investigation, demonstrate that the liver responds in order to increase defenses in the blood that prevent localized infections from spreading throughout the body.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.
Near death experiences have often been described as "seeing life flash before one's eyes" or "intense feelings of joy and peace." Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.
› Verified 2 days ago